LUX MED Onkologia – Szpital Szamocka

What LUX MED Onkologia – Szpital Szamocka does

LUX MED Onkologia sp. z o.o. is a private Polish oncology hospital network operating as a subsidiary of Grupa LUX MED, one of the largest private healthcare providers in Poland. The company runs six facilities across the Masovian and Łódź voivodeships: four hospitals in Warsaw (Szpital Szamocka, Szpital św. Wincentego, Szpital Fieldorfa, Szpital św. Elżbiety), one endotherapy center in Łódź, and a rehabilitation center in Warsaw. The network provides comprehensive cancer diagnosis and treatment under NFZ (Narodowy Fundusz Zdrowia) contracts, covering surgical oncology, clinical oncology and chemotherapy, immunotherapy, hormone therapy, drug programs, diagnostic imaging, endoscopic procedures, and psycho-oncological support. It holds specialist Breast Cancer Unit (BCU) and Colorectal Cancer Unit (CCU) designations — among a limited number of such certified centers in Poland — and operates a robotic surgery program (da Vinci system) for prostate, colorectal, and endometrial cancers, including a national first in certified robotic gynecology surgical assistance.

The underlying technology stack combines da Vinci-class robotic surgical platforms, advanced endoscopic imaging (colonoscopy, gastroscopy, EUS, ESD, POEM), diagnostic imaging (CT, MRI, ultrasound, mammography with tomosynthesis), and clinical laboratory diagnostics including histopathology and genetic profiling. Multidisciplinary care is delivered through dedicated breast, colorectal, prostate, and endometrial cancer coordinators, with a Primary Nursing model implemented since 2017. The organization's revenue model is primarily NFZ reimbursement across hospital services, outpatient specialist care, diagnostics, and rehabilitation, supplemented by commercial private-pay services for non-NFZ-covered treatments and imaging. Clinical trials are offered free of charge under Bioethics Committee approval, providing patient access to investigational therapies without direct revenue capture. Distribution is direct through owned facilities, with patient access via GP/specialist referrals, the DILO fast-track oncology card, the central infoline, online contact forms, and self-referral for screening programs. The organization is accredited by the Minister of Health and has received EU funding through the Polish Recovery Plan (KPO) for infrastructure modernization.

Name

LUX MED Onkologia – Szpital Szamocka

Legal name

LUX MED Onkologia sp. z o.o.

Website

https://onkologia.luxmed.pl

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

LUX MED Onkologia is a private Polish oncology hospital network operating six facilities across Warsaw and Łódź, providing NFZ-funded cancer diagnosis, robotic and surgical oncology, chemotherapy, immunotherapy, endoscopy, and rehabilitation under specialized BCU and CCU designations.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Diagnostic Imaging Centers (621512)

SIC

Services-Hospitals (8060), Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Surgical Oncology (HLAKAFAG), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

Keywords

• Oncology hospital services
• Cancer treatment
• Robotic surgery
• Clinical oncology
• Diagnostic imaging

Headquarters

HQ city

Warszawa, Mazowieckie

HQ country

Poland

HQ region

Europe

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. NFZ (Narodowy Fundusz Zdrowia) Reimbursement: Primary revenue stream from government-mandated public health insurance reimbursements. All citizens covered by universal health insurance receive diagnostic and therapeutic oncology services at LUX MED Onkologia under the same conditions as public hospitals, in a private hospital setting. Covers all treatment modalities including surgery, chemotherapy, immunotherapy, hormone therapy, radiotherapy, and diagnostic procedures.
2. Commercial / Private Pay Services: Supplementary revenue from privately funded medical services not covered by NFZ or commercial versions of diagnostic and treatment services. Includes specialist outpatient consultations, certain imaging modalities (e.g., mammography with tomosynthesis), and potentially experimental treatments outside drug program coverage.
3. Clinical Trials (Badania Kliniczne): Free-of-charge access to investigational treatments through participation in clinical trials, approved by Bioethics Committee and registered in Central Clinical Trials Registry. Generates no direct revenue but provides early access to innovative therapies.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

LUX MED Onkologia operates a network of specialized oncology hospitals in Warsaw and Łódź, Poland, providing comprehensive cancer diagnosis and treatment. Core services include surgical oncology with da Vinci robotic-assisted surgery for prostate, colorectal, and endometrial cancers, clinical oncology (chemotherapy, immunotherapy, hormone therapy, targeted therapies), advanced diagnostic imaging (CT, MRI, mammography with tomosynthesis), endoscopic procedures, NFZ-funded screening programs, drug programs, clinical trials, and supportive care including psycho-oncology, dietetics, and rehabilitation.

Product overview

LUX MED Onkologia is a network of specialized oncology hospitals in Warsaw and Łódź, Poland, providing comprehensive cancer diagnosis and treatment services under NFZ (National Health Fund) agreements. The network comprises six facilities: Szpital Szamocka (main clinical oncology and chemotherapy hospital), Szpital św. Wincentego (robotic surgery center), Szpital Fieldorfa (clinical oncology), Szpital św. Elżbiety (robotic surgery and cardiology), Endoterapia in Łódź (endoscopy), and Centrum Rehabilitacji (rehabilitation). Services include surgical oncology with advanced robotic surgery using the da Vinci system for colorectal, prostate, and endometrial cancers; clinical oncology with chemotherapy, immunotherapy, and hormone therapy; comprehensive diagnostic imaging; cancer prevention screening programs (mammography, colonoscopy, cytology); drug programs providing access to modern therapies; clinical trials; and supportive care including psycho-oncology, dietetics, and rehabilitation. The network is recognized as one of the leaders in oncology surgery rankings in Poland and operates specialized competency centers for breast cancer (Breast Cancer Unit) and colorectal cancer (Colorectal Cancer Unit).

Differentiator

Problem solved

Functional benefit

Products and services

• Szpital Szamocka
• Szpital św. Wincentego
• Szpital Fieldorfa
• Szpital św. Elżbiety
• Endoterapia (Łódź)
• Centrum Rehabilitacji
• Robotic Surgery (Chirurgia Robotyczna)
• Clinical Oncology and Chemotherapy
• Fast Track Oncology (Szybka Terapia Onkologiczna)
• Clinical Trials (Badania Kliniczne)
• Drug Programs (Programy Lekowe)
• Cancer Prevention Programs (Profilaktyka Nowotworów)
• Diagnostic Imaging (Diagnostyka Obrazowa)
• Psychological Support (Wsparcie Psychologiczne)
• Dietetic Services (Dietetyk)

Quantifiable outcome

• NFZ-funded robotic surgery reduces hospital stay to as little as 1-2 days post-operatively for endometrial cancer patients
• +2 more outcomes

Named customers5 records

Segments7 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered minor.

• Fundacja OnkoCafe (OnkoCafe Foundation)minorStrategic or Co-development PartnerFundacja OnkoCafe is a patient support foundation. LUX MED Onkologia partners with the foundation to provide additional support services and resources for oncology patients. The partnership appears in the 'Nasi partnerzy' (Our partners) section of the website.
• Narodowy Instytut Onkologii (National Oncology Institute – NIO)minorStrategic or Co-development PartnerNarodowy Instytut Onkologii (NIO) – National Oncology Institute (Poland) is listed as a partner in the 'Nasi partnerzy' section. NIO serves as the premier national reference center for cancer research, treatment guidelines, and professional training in Poland.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medicover: Major private healthcare operator in Poland and Central Europe offering integrated hospitals, clinics, and diagnostics. Comparable as a peer parent/operator and competes for NFZ-funded specialty volumes, though oncology is not its core focus.
• Charité Comprehensive Cancer Center: Major academic cancer center in Berlin operating as a designated oncology center of excellence. Comparable as a peer benchmark for BCU/CCU-style specialist center accreditation, multidisciplinary care, and integration with clinical research.
• Enel-Med: One of Poland's largest private healthcare networks, offering outpatient and inpatient services under NFZ and commercial contracts. Overlaps with LUX MED Onkologia as a private-sector NFZ contractor in specialty and diagnostic services.

Direct peers

• Affidea Poland: Pan-European private operator of diagnostic and cancer treatment centers with significant Polish footprint. Overlaps with LUX MED Onkologia in oncology diagnostics, imaging, and outpatient oncology services, often competing for NFZ contracts in oncology-adjacent specialties.
• GenesisCare: Global private cancer care operator with European presence, specializing in radiotherapy, medical oncology, and advanced diagnostics. Comparable as a private-sector cancer specialty provider scaling across multiple geographies with technology-driven treatment.
• Maria Skłodowska-Curie National Research Institute of Oncology (NIO/COI): Poland's premier state-run oncology reference center, listed as a partner on LUX MED Onkologia's website. Provides the full continuum of cancer care under NFZ and competes directly for specialist oncology volumes, particularly in complex and hematological cases.
• Istituto Europeo di Oncologia (IEO): Leading European private nonprofit cancer specialty hospital in Milan. Comparable as a model for comprehensive cancer-only hospital operations with multidisciplinary specialist units, research integration, and advanced surgical oncology including robotics.
• NU-MED Group: Polish private oncology hospital network operating multiple cancer treatment centers across Poland. Direct competitor offering chemotherapy, radiotherapy, and surgical oncology under NFZ contracts, overlapping closely with LUX MED Onkologia's service mix and payer model.

Regional players

• Swissmed Centrum Zdrowia: Private hospital in Gdańsk offering multi-specialty inpatient services under NFZ. Comparable as a Polish private-sector NFZ-contracted hospital operator competing in select specialty and surgical markets outside Warsaw.
• Centrum Medyczne Damiana: Warsaw-based private healthcare operator offering specialist outpatient and surgical services under NFZ. Comparable as a Warsaw private-sector NFZ competitor in diagnostics, specialist consultations, and surgical specialties adjacent to oncology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lux-med-onkologia-%E2%80%93-szpital-szamocka

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LUX MED Onkologia – Szpital Szamocka